Hee Jin Cho
机构: Department of Biomedical Convergence Science and Technology, Kyungpook National University
每年引用次数
引用次数
引用: 4,260
H-指数: 25
I10-指数 : 35
出版物: 45
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Seung Won Choi , Yeri Lee , Kayoung Shin , Harim Koo
Cell Death and Disease 12 ( 4) 374 -374
2021
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Seung Won Choi , Yeri Lee , Kayoung Shin , Harim Koo
Cell Death and Disease 12 ( 4) 374 -374
2021
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.
Samuel J. Klempner , Woong-Yang Park , Won Ki Kang , Seung Tae Kim
Cancer Discovery
1
2021
Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme
Wonyoung Kang , Sung Heon Kim , Hee Jin Cho , Juyoun Jin
Oncotarget 6 ( 29) 27239 -27251
17
2015
Tumor edge architecture in glioblastoma is constructed by inter-cellular signals from vascular endothelial cells
Soniya Bastola , Marat S Pavlyukov , Yasmin Ghochani , Sree Deepthi Muthukrishnan
bioRxiv
3
2020
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
Sejin Oh , Jeonghun Yeom , Hee Jin Cho , Ju-Hwa Kim
Nature Communications 11 ( 1) 3288
7
2020
FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Yeri Lee , Kang Ho Kim , Dong Geon Kim , Hee Jin Cho
PLOS ONE 10 ( 10)
114
2015
Spatial heterogeneity of glioblastoma cells reveals sensitivity to NAD+ depletion at tumor edge
Daisuke Yamashita , Davide Botta , Hee Jin Cho , Xiaoxian Guo
bioRxiv
2020
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
Jason K. Sa , Jae Ryoung Hwang , Young-Jae Cho , Ji-Yoon Ryu
Genome Biology 20 ( 1) 253
4
2019
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
Jason K Sa , Nakho Chang , Hye Won Lee , Hee Jin Cho
Genome Biology 21 ( 1) 216
60
2020
Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.
Kayoung Shin , Hyemi Shin , Hee Jin Cho , Hyunju Kang
Cancers 12 ( 3) 549
5
2020
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
Seung Won Choi , Daniel I. S. Rosenbloom , In-Hee Lee , Yong Jae Shin
Nature Genetics 50 ( 10) 1399 -1411
82
2018
Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma
Young Taek Oh , Hee Jin Cho , Jinkuk Kim , Ji-Hyun Lee
PLOS ONE 9 ( 8) 0103327
32
2014
Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Jinlong Yin , Young Taek Oh , Jeong-Yub Kim , Sung Soo Kim
Cancer Research 77 ( 18) 4973 -4984
30
2017
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang , Baoli Hu , Xin Hu , Hoon Kim
Cancer Cell 32 ( 1) 152 -152
1,124
2017
Erratum: Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (Cancer Cell (2017) 32(1) (42–56.e6)(S1535610817302532)(10.1016/j.ccell.2017.06.003))
Qianghu Wang , Baoli Hu , Xin Hu , Hoon Kim
Cancer Cell 33 ( 1)
69
2018
Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Hye Won Lee , Kyeung Min Joo , Joung Eun Lim , Hyun Jung Cho
Molecular Cancer Research 11 ( 11) 1375 -1386
16
2013
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
Nam-Gu Her , Jeong-Woo Oh , Yun Jeong Oh , Suji Han
Cell Death and Disease 9 ( 8) 792 -792
18
2018
Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.
Min-Sang Lee , Hee Jin Cho , Jung Yong Hong , Jeeyun Lee
Therapeutic Advances in Medical Oncology 12 1758835920965842
1
2020
MYC amplification at diagnosis drives therapy-induced hypermutation of recurrent glioma
Jiguang Wang , Quanhua Mu , Ruichao Chai , Hanjie Liu
2021